Phase 4 Psoriasis Clinical Trials
28 recruitingPhase 4
What is a Phase 4 trial?
Phase 4 trials, also called post-marketing studies, are conducted after a treatment has been approved and is available to the public. They monitor long-term effectiveness and safety in a broader population.
Showing 1–20 of 28 trials
Recruiting
Phase 4
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
PsoriasisOverweight or Obesity
Eli Lilly and Company200 enrolled40 locationsNCT06857942
Recruiting
Phase 4
Immune Spatial Features of Guselkumab Cutaneous Response
Psoriasis of Scalp
University of California, San Francisco10 enrolled1 locationNCT05858632
Recruiting
Phase 4
Psoriatic Immune Response to Tildrakizumab
Psoriasis Vulgaris
University of California, San Francisco10 enrolled1 locationNCT05390515
Recruiting
Phase 4
Correction of Psoriatic T Cell Signatures by Deucravacitinib
Psoriasis Vulgaris
University of California, San Francisco25 enrolled1 locationNCT05858645
Recruiting
Phase 4
Treatment of Psoriasis With Depression and/or Anxiety With Methotrexate vs Combined Methotrexate and Antidepressant
DepressionAnxietyPsoriasis
Cairo University40 enrolled1 locationNCT07432815
Recruiting
Phase 4
Development of Predictive Psoriasis Response Endotypes Using Single Cell Transcriptomics
Psoriasis
University Hospitals Cleveland Medical Center56 enrolled1 locationNCT05270733
Recruiting
Phase 4
Multi-Center PAMPA Study
Psoriasis
NYU Langone Health176 enrolled5 locationsNCT05004727
Recruiting
Phase 4
Proactive TDM Versus Standard Use of Biologics in Psoriasis
Psoriasis Vulgaris
University Hospital, Ghent210 enrolled15 locationsNCT06398106
Recruiting
Phase 4
Effects of Semaglutide on Clinical Outcomes and Metabolic Inflammation in Psoriasis
Diabetes Mellitus, Type 2Obesity, OverweightPsoriasis (PsO)
Hospital Universitario Dr. Jose E. Gonzalez62 enrolled1 locationNCT07401992
Recruiting
Phase 4
Bimekizumab in Plaque Psoriasis
Plaque Psoriasis
Icahn School of Medicine at Mount Sinai60 enrolled2 locationsNCT06336343
Recruiting
Phase 4
A Safety and Pharmacokinetics Study of IDP-118 Lotion in Pediatric Participants With Plaque Psoriasis
Psoriasis
Bausch Health Americas, Inc.45 enrolled9 locationsNCT03988439
Recruiting
Phase 4
A Safety and Pharmacokinetics Study of IDP-122 Lotion in Pediatric Participants With Plaque Psoriasis
Psoriasis
Bausch Health Americas, Inc.45 enrolled9 locationsNCT03987763
Recruiting
Phase 4
A Multi-center RCT Clinical Trial on Personalized Precision Medicine for Patients With Psoriasis and Psoriatic Arthritis and Investigation on Cardiovascular Biomarkers
PsoriasisPsoriasis ArthritisBiologics
Taichung Veterans General Hospital50 enrolled2 locationsNCT07149792
Recruiting
Phase 4
Potential Role of Guselkumab in Modulating PAIN Perception and Related Gene Pathways: a Proof-of-concept Study.
Psoriasis Arthritis
Fondazione Policlinico Universitario Campus Bio-Medico26 enrolled1 locationNCT06974474
Completed
Phase 4
Pilot study of a branded (marketed) formulation betamethasone dipropionate called Diprosone® OV ointment applied to the skin in healthy male and female volunteers to determine the appropriate dose duration (ED50) for use in a pivotal in vivo bioequivalence study.
Diprosone OV ointment is indicated for the topical treatment of eczema and psoriasis in children and adults.
Zenith Technology Corporation Limited12 enrolled1 locationACTRN12623001181695
Completed
Phase 4
Pilot study of a branded (marketed) formulation betamethasone dipropionate called Diprosone® ointment applied to the skin in healthy male and female volunteers to determine the appropriate dose duration (ED50) for use in a pivotal in vivo bioequivalence study.
Diprosone ointment is indicated for the topical treatment of eczema and psoriasis in children and adults.
Zenith Technology Corporation Limited12 enrolled1 locationACTRN12623001179628
Completed
Phase 4
Pilot study of a branded (marketed) formulation betamethasone dipropionate called Diprosone® cream applied to the skin in healthy male and female volunteers to determine the appropriate dose duration (ED50) for use in a pivotal in vivo bioequivalence study.
Diprosone cream is indicated for the topical treatment of eczema and psoriasis in children and adults.
Zenith Technology Corporation Limited12 enrolled1 locationACTRN12623000887673
Completed
Phase 4
Pilot study of a branded (marketed) formulation methylprednisolone aceponate called Advantan fatty ointment applied to the skin in healthy male and female volunteers to determine the appropriate dose duration (ED50) for use in a pivotal in vivo bioequivalence study.
Advantan fatty ointment is indicated for the topical treatment of eczema and psoriasis in children and adults.
Zenith Technology Corporation Limited12 enrolled1 locationACTRN12623000272695
Recruiting
Phase 4
Outcomes With Treatment and Withdraw of Ixekizumab in Patients With Plaque Psoriasis
Plaque Psoriasis
Singapore General Hospital40 enrolled1 locationNCT04537689
Completed
Phase 4
Pilot study of a branded (marketed) formulation methylprednisolone aceponate called Advantan ointment applied to the skin in healthy male and female volunteers to determine the appropriate dose duration (ED50) for use in a pivotal in vivo bioequivalence study.
Advantan ointment is indicated for the topical treatment of eczema and psoriasis in children and adults.
Zenith Technology Corporation Limited12 enrolled1 locationACTRN12622001295730